NSAID-exacerbated respiratory disease: a population study.
Heidi AndersénPinja IlmarinenJasmin HonkamäkiLeena E TuomistoHanna Hisinger-MölkänenHelena BackmanBo LundbäckEva RönmarkTari HaahtelaAnssi SovijärviLauri LehtimäkiPäivi PiiriläHannu KankaanrantaPublished in: ERJ open research (2022)
We conclude that the prevalence of N-ERD was 1.4% in a representative Finnish adult population sample. Older age, family history of asthma or allergic rhinitis, cumulative exposure to tobacco smoke, secondhand smoke, and occupational exposures increased odds of N-ERD. N-ERD was associated with significant morbidity.